- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-8-8-mer
- Ligands
- 8 x CAP: 2-CARBOXYARABINITOL-1,5-DIPHOSPHATE(Non-covalent)
- 8 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 8 residues within 4Å:- Chain A: K.175, K.177, K.201, D.203, E.204, H.294
- Chain B: N.123
- Ligands: CAP.1
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:D.203, A:E.204
MG.7: 7 residues within 4Å:- Chain A: N.123
- Chain B: K.177, K.201, D.203, E.204, H.294
- Ligands: CAP.8
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:D.203, B:E.204
MG.13: 8 residues within 4Å:- Chain C: K.175, K.177, K.201, D.203, E.204, H.294
- Chain D: N.123
- Ligands: CAP.14
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:D.203, C:E.204
MG.20: 8 residues within 4Å:- Chain C: N.123
- Chain D: K.175, K.177, K.201, D.203, E.204, H.294
- Ligands: CAP.21
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:D.203, D:E.204
MG.26: 8 residues within 4Å:- Chain E: K.175, K.177, K.201, D.203, E.204, H.294
- Chain F: N.123
- Ligands: CAP.27
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:D.203, E:E.204
MG.31: 8 residues within 4Å:- Chain E: N.123
- Chain F: K.175, K.177, K.201, D.203, E.204, H.294
- Ligands: CAP.32
2 PLIP interactions:2 interactions with chain F- Metal complexes: F:D.203, F:E.204
MG.35: 8 residues within 4Å:- Chain G: K.175, K.177, K.201, D.203, E.204, H.294
- Chain H: N.123
- Ligands: CAP.36
2 PLIP interactions:2 interactions with chain G- Metal complexes: G:D.203, G:E.204
MG.43: 7 residues within 4Å:- Chain G: N.123
- Chain H: K.177, K.201, D.203, E.204, H.294
- Ligands: CAP.44
2 PLIP interactions:2 interactions with chain H- Metal complexes: H:D.203, H:E.204
- 46 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 8 residues within 4Å:- Chain A: G.16, V.17, K.18, Y.20, T.65, W.66, T.67, T.68
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: Y.20, V.48, E.52, A.129
- Chain B: F.469
Ligand excluded by PLIPEDO.5: 9 residues within 4Å:- Chain A: R.295, H.298, F.311, S.328, G.329, E.336, G.337, F.345, D.473
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: K.466, F.467, E.468, F.469
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain B: Y.24, G.64, T.68, V.69, D.72, L.77
- Ligands: EDO.10
Ligand excluded by PLIPEDO.10: 9 residues within 4Å:- Chain B: G.16, V.17, K.18, Y.20, T.65, W.66, T.67, T.68
- Ligands: EDO.9
Ligand excluded by PLIPEDO.11: 4 residues within 4Å:- Chain A: F.469
- Chain B: Y.20, E.52, A.129
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain B: K.466, F.467, E.468, F.469
Ligand excluded by PLIPEDO.15: 8 residues within 4Å:- Chain C: G.16, V.17, K.18, Y.20, T.65, W.66, T.67, T.68
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain C: L.270
- Chain D: L.270
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain C: Y.20, V.48, E.52, A.129
- Chain D: F.469
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain C: K.466, F.467, E.468, F.469
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain C: R.295, F.311, F.345, D.473
Ligand excluded by PLIPEDO.22: 9 residues within 4Å:- Chain D: G.16, V.17, K.18, Y.20, T.65, W.66, T.67, T.68
- Ligands: EDO.24
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain D: K.466, F.467, E.468, F.469
Ligand excluded by PLIPEDO.24: 7 residues within 4Å:- Chain D: Y.24, G.64, T.68, V.69, D.72, L.77
- Ligands: EDO.22
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain D: R.295, H.298, F.311, S.328, G.329, E.336, G.337, F.345
Ligand excluded by PLIPEDO.28: 7 residues within 4Å:- Chain E: Y.24, G.64, T.68, V.69, D.72, L.77
- Ligands: EDO.29
Ligand excluded by PLIPEDO.29: 9 residues within 4Å:- Chain E: G.16, V.17, K.18, Y.20, T.65, W.66, T.67, T.68
- Ligands: EDO.28
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain E: K.466, F.467, E.468, F.469
Ligand excluded by PLIPEDO.33: 7 residues within 4Å:- Chain F: G.16, K.18, Y.20, T.65, W.66, T.67, T.68
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain E: F.469
- Chain F: Y.20, E.52
Ligand excluded by PLIPEDO.37: 7 residues within 4Å:- Chain G: Y.24, G.64, T.68, V.69, D.72, L.77
- Ligands: EDO.38
Ligand excluded by PLIPEDO.38: 9 residues within 4Å:- Chain G: G.16, V.17, K.18, Y.20, T.65, W.66, T.67, T.68
- Ligands: EDO.37
Ligand excluded by PLIPEDO.39: 4 residues within 4Å:- Chain G: K.466, F.467, E.468, F.469
Ligand excluded by PLIPEDO.40: 5 residues within 4Å:- Chain G: R.295, F.311, G.337, F.345, D.473
Ligand excluded by PLIPEDO.41: 7 residues within 4Å:- Chain G: L.270, G.273, F.274
- Chain H: L.270, T.271, G.272, G.273
Ligand excluded by PLIPEDO.42: 3 residues within 4Å:- Chain G: Y.20, E.52, A.129
Ligand excluded by PLIPEDO.45: 8 residues within 4Å:- Chain H: G.16, V.17, K.18, Y.20, T.65, W.66, T.67, T.68
Ligand excluded by PLIPEDO.46: 3 residues within 4Å:- Chain H: Y.20, E.52, A.129
Ligand excluded by PLIPEDO.47: 4 residues within 4Å:- Chain H: K.466, F.467, E.468, F.469
Ligand excluded by PLIPEDO.48: 7 residues within 4Å:- Chain H: R.295, H.298, D.302, F.311, S.328, E.336, F.345
Ligand excluded by PLIPEDO.49: 6 residues within 4Å:- Chain C: Y.226, K.227, A.230
- Chain I: K.49, E.55, D.69
Ligand excluded by PLIPEDO.50: 7 residues within 4Å:- Chain H: Y.226, K.227, A.230
- Chain J: K.49, E.55, S.56, D.69
Ligand excluded by PLIPEDO.51: 7 residues within 4Å:- Chain J: G.37, W.38, I.39, M.80, F.81, G.82, C.83
Ligand excluded by PLIPEDO.52: 6 residues within 4Å:- Chain K: G.37, W.38, I.39, F.81, G.82, C.83
Ligand excluded by PLIPEDO.53: 7 residues within 4Å:- Chain E: Y.226, K.227, A.230
- Chain K: K.49, E.55, S.56, D.69
Ligand excluded by PLIPEDO.54: 7 residues within 4Å:- Chain B: Y.226, K.227, A.230
- Chain L: K.49, E.55, S.56, D.69
Ligand excluded by PLIPEDO.55: 6 residues within 4Å:- Chain A: G.10
- Chain L: G.37, W.38, I.39, F.81, G.82
Ligand excluded by PLIPEDO.56: 5 residues within 4Å:- Chain G: Y.226, K.227, A.230
- Chain M: K.49, E.55
Ligand excluded by PLIPEDO.57: 7 residues within 4Å:- Chain H: G.10
- Chain M: G.37, W.38, I.39, F.81, G.82, C.83
Ligand excluded by PLIPEDO.58: 8 residues within 4Å:- Chain D: Y.226, K.227, A.230
- Chain N: K.49, E.55, S.56, D.69, N.70
Ligand excluded by PLIPEDO.59: 6 residues within 4Å:- Chain N: G.37, W.38, I.39, F.81, G.82, C.83
Ligand excluded by PLIPEDO.60: 7 residues within 4Å:- Chain A: Y.226, K.227, A.230
- Chain O: K.49, E.55, S.56, D.69
Ligand excluded by PLIPEDO.61: 7 residues within 4Å:- Chain O: G.37, W.38, I.39, F.81, G.82, C.83, R.84
Ligand excluded by PLIPEDO.62: 8 residues within 4Å:- Chain F: Y.226, K.227, A.230
- Chain P: K.49, E.55, S.56, D.69, N.70
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karkehabadi, S. et al., Structural Analysis of Altered Large-Subunit Loop-6-Carboxy-Terminus Interactions that Influence Catalytic Efficiency and Co2 O2 Specificity of Ribulose-1,5-Bisphosphate Carboxylase Oxygenase. Biochemistry (2007)
- Release Date
- 2007-07-31
- Peptides
- RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN: ABCDEFGH
RIBULOSE BISPHOSPHATE CARBOXYLASE SMALL CHAIN 1: IJKLMNOP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
P
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-8-8-mer
- Ligands
- 8 x CAP: 2-CARBOXYARABINITOL-1,5-DIPHOSPHATE(Non-covalent)
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 46 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karkehabadi, S. et al., Structural Analysis of Altered Large-Subunit Loop-6-Carboxy-Terminus Interactions that Influence Catalytic Efficiency and Co2 O2 Specificity of Ribulose-1,5-Bisphosphate Carboxylase Oxygenase. Biochemistry (2007)
- Release Date
- 2007-07-31
- Peptides
- RIBULOSE BISPHOSPHATE CARBOXYLASE LARGE CHAIN: ABCDEFGH
RIBULOSE BISPHOSPHATE CARBOXYLASE SMALL CHAIN 1: IJKLMNOP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
P